157 related articles for article (PubMed ID: 12101631)
1. Development of a urinary biomarker for exposure to the organophosphate propetamphos: data from an oral and dermal human volunteer study.
Garfitt SJ; Jones K; Mason HJ; Cocker J
Biomarkers; 2002; 7(2):113-22. PubMed ID: 12101631
[TBL] [Abstract][Full Text] [Related]
2. Oral and dermal exposure to propetamphos: a human volunteer study.
Garfitt SJ; Jones K; Mason HJ; Cocker J
Toxicol Lett; 2002 Aug; 134(1-3):115-8. PubMed ID: 12191868
[TBL] [Abstract][Full Text] [Related]
3. Oral and dermal absorption of chlorpyrifos: a human volunteer study.
Griffin P; Mason H; Heywood K; Cocker J
Occup Environ Med; 1999 Jan; 56(1):10-3. PubMed ID: 10341740
[TBL] [Abstract][Full Text] [Related]
4. Exposure to the organophosphate diazinon: data from a human volunteer study with oral and dermal doses.
Garfitt SJ; Jones K; Mason HJ; Cocker J
Toxicol Lett; 2002 Aug; 134(1-3):105-13. PubMed ID: 12191867
[TBL] [Abstract][Full Text] [Related]
5. Biological monitoring of exposure to organophosphate pesticides.
Cocker J; Mason HJ; Garfitt SJ; Jones K
Toxicol Lett; 2002 Aug; 134(1-3):97-103. PubMed ID: 12191866
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of propetamphos following intravenous administration in the F344 rat.
Dix K; Burka LT; Dauterman WC
J Biochem Toxicol; 1992; 7(4):199-204. PubMed ID: 1293308
[TBL] [Abstract][Full Text] [Related]
7. Biological monitoring for exposure to methamidophos: a human oral dosing study.
Garner F; Jones K
Toxicol Lett; 2014 Dec; 231(2):277-81. PubMed ID: 25310994
[TBL] [Abstract][Full Text] [Related]
8. Toxicokinetics of a urinary metabolite of tebuconazole following controlled oral and dermal administration in human volunteers.
Oerlemans A; Verscheijden LFM; Mol JGJ; Vermeulen RCH; Westerhout J; Roeleveld N; Russel FGM; Scheepers PTJ
Arch Toxicol; 2019 Sep; 93(9):2545-2553. PubMed ID: 31359083
[TBL] [Abstract][Full Text] [Related]
9. Toxicokinetics of bisphenol-S and its glucuronide in plasma and urine following oral and dermal exposure in volunteers for the interpretation of biomonitoring data.
Khmiri I; Côté J; Mantha M; Khemiri R; Lacroix M; Gely C; Toutain PL; Picard-Hagen N; Gayrard V; Bouchard M
Environ Int; 2020 May; 138():105644. PubMed ID: 32179324
[TBL] [Abstract][Full Text] [Related]
10. Kinetic time courses of lambda-cyhalothrin metabolites after dermal application of Matador EC 120 in volunteers.
Khemiri R; Côté J; Fetoui H; Bouchard M
Toxicol Lett; 2018 Oct; 296():132-138. PubMed ID: 30120931
[TBL] [Abstract][Full Text] [Related]
11. Biomonitoring of 4,4'-methylene dianiline by measurement in hydrolysed urine and plasma after epicutaneous exposure in humans.
Brunmark P; Bruze M; Skerfving S; Skarping G
Int Arch Occup Environ Health; 1995; 67(2):95-100. PubMed ID: 7672863
[TBL] [Abstract][Full Text] [Related]
12. Human volunteer study on the influence of exposure duration and dilution of dermally applied N-methyl-2-pyrrolidone (NMP) on the urinary elimination of NMP metabolites.
Keener SA; Wrbitzky R; Bader M
Int Arch Occup Environ Health; 2007 Feb; 80(4):327-34. PubMed ID: 16897094
[TBL] [Abstract][Full Text] [Related]
13. Biomarkers of Exposure to Pyrimethanil After Controlled Human Experiments.
Faniband M; Ekman E; Littorin M; Maxe M; Larsson E; Lindh CH
J Anal Toxicol; 2019 May; 43(4):277-283. PubMed ID: 30462228
[TBL] [Abstract][Full Text] [Related]
14. Documenting the kinetic time course of lambda-cyhalothrin metabolites in orally exposed volunteers for the interpretation of biomonitoring data.
Khemiri R; Côté J; Fetoui H; Bouchard M
Toxicol Lett; 2017 Jul; 276():115-121. PubMed ID: 28539253
[TBL] [Abstract][Full Text] [Related]
15. The metabolism of cypermethrin in man: differences in urinary metabolite profiles following oral and dermal administration.
Woollen BH; Marsh JR; Laird WJ; Lesser JE
Xenobiotica; 1992 Aug; 22(8):983-91. PubMed ID: 1413886
[TBL] [Abstract][Full Text] [Related]
16. A toxicokinetic model of malathion and its metabolites as a tool to assess human exposure and risk through measurements of urinary biomarkers.
Bouchard M; Gosselin NH; Brunet RC; Samuel O; Dumoulin MJ; Carrier G
Toxicol Sci; 2003 May; 73(1):182-94. PubMed ID: 12657741
[TBL] [Abstract][Full Text] [Related]
17. Human metabolism and excretion kinetics of the surfactant 2,4,7,9-tetramethyl-5-decyne-4,7-diol (TMDD) after oral and dermal administration.
Pluym N; Roegner N; Peschel O; Leibold E; Scherer G; Scherer M
Arch Toxicol; 2023 Sep; 97(9):2419-2428. PubMed ID: 37392209
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of aminomethylpropanol in rats following oral and a novel dermal study design.
Saghir SA; Clark AJ; McClymont EL; Staley JL
Food Chem Toxicol; 2008 Feb; 46(2):678-87. PubMed ID: 17961896
[TBL] [Abstract][Full Text] [Related]
19. Urinary metabolite excretion after oral dosage of bis(2-propylheptyl) phthalate (DPHP) to five male volunteers--characterization of suitable biomarkers for human biomonitoring.
Leng G; Koch HM; Gries W; Schütze A; Langsch A; Brüning T; Otter R
Toxicol Lett; 2014 Dec; 231(2):282-8. PubMed ID: 24973492
[TBL] [Abstract][Full Text] [Related]
20. Biotransformation and toxicokinetics of musk xylene in humans.
Riedel J; Dekant W
Toxicol Appl Pharmacol; 1999 Jun; 157(2):145-55. PubMed ID: 10366547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
